CD226 and neoplasm: Indeed, it interacts with the activating receptor DNAX-associated molecule-1 (DNAM-1) expressed on the surface of cytotoxic T cells and natural killer (NK) cells, thus favoring tumor cell recognition and elimination by innate and adaptive immune responses [2,18].